What Schedule Is Levocetirizine Dihydrochloride?
Levocetirizine Dihydrochloride scheduling and classification across Australia, United States, and international jurisdictions. Also known as XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack, XYZAL levocetirizine dihydrochloride 5 mg/mL oral drops bottle.
Levocetirizine Dihydrochloride (XYZAL levocetirizine hydrochloride 5 mg film coated tablet blister pack) is classified as S2 (Pharmacy Medicine - available from a pharmacy without a prescription, but must be provided by a pharmacist) under the Therapeutic Goods Administration (TGA) in Australia. It is FDA approved in the United States.
Key Takeaways
- Australia (TGA): S2 - Pharmacy Medicine - available from a pharmacy without a prescription, but must be provided by a pharmacist
- United States (FDA): Approved (Rx only)
- Risk level: Low (1 points)
Scheduling by Jurisdiction
| Jurisdiction | Regulatory Body | Classification | Status |
|---|---|---|---|
| Australia | TGA (Therapeutic Goods Administration) | S2 | Not PBS listed |
| United States | FDA / DEA | Rx only (not DEA scheduled) | FDA approved |
What S2 Means for Levocetirizine Dihydrochloride
Levocetirizine Dihydrochloride is classified as S2 under the TGA Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). Pharmacy Medicine - available from a pharmacy without a prescription, but must be provided by a pharmacist.
Claims and Workers Compensation Implications
When Levocetirizine Dihydrochloride (S2) appears on a claimant's medication list, the scheduling classification affects how claims professionals should assess and manage the claim.
Check this medication against your full medication list
Check Levocetirizine Dihydrochloride scheduling, interactions, and compliance across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.